Active substances
Calcium chloride + Potassium chloride + Sodium chloride
- SFDA 10
- US FDA 8
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| RINGER SOLUTION I.V INFUSION | 8.6,0.30,0.33 g/ml,g/ml,g/ml | Intravenous infusion · Intravenous use | 1 Bag | SAR 4.95 | Generic · Prescription | GULF INJECT | Valid |
| RINGERS INJECATION 500 ML SOLUTION | 0.85,0.03,0.33 %,%,% | Solution · Intravenous use | 1 Bag | SAR 4.75 | Generic · Prescription | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| RINGERS SOLUTION | 8.6,0.30,0.33 g/ml,g/ml,g/ml | Solution · Intravenous use | 1 Bag | SAR 11.10 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| RINGERS SOLUTION | 8.6,0.30,0.33 g/ml,g/ml,g/ml | Solution · Intravenous use | 1 Bottle | SAR 3.40 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| RINGERS SOLUTION | 8.6,0.30,0.33 g/ml,g/ml,g/ml | Solution · Intravenous use | 1 Bottle | SAR 9.25 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| RINGERS SOLUTION | 8.6,0.3,0.33 g/ml,g/ml,g/ml | Solution · Intravenous use | 1 Bottle | SAR 8.00 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| RINGERS SOLUTION | 8.6,0.30,0.33 g/ml,g/ml,g/ml | Solution · Intravenous use | 1 Bottle | SAR 9.00 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| RINGERS SOLUTION | 8.6,0.30,0.33 g/ml,g/ml,g/ml | Solution · Intravenous use | 1 Bottle | SAR 10.75 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by MAH · Not Marketed |
| RINGERS SOLUTION FOR I.V. INFUSION IN VIAFLEX | 8.6,0.3,0.33 g/ml,g/ml,g/ml | Solution · Intravenous use | 1 Bag | SAR 11.10 | Generic · Prescription | Baxter Company Limited | Withdrawn by MAH · Not Marketed |
| RINGERS SOLUTION FOR I.V. INFUSION IN VIAFLEX | 8.6,0.3,0.33 g/ml,g/ml,g/ml | Solution · Intravenous use | 1 Bag | SAR 5.45 | Generic · Prescription | Baxter Company Limited | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ACUTE KIDNEY INJURY (AKI); ACUTE PANCREATITIS; ANESTHESIA-SUPPORTIVE AGENTS/ FLUID RESUSCITATION (UNCONTROLLED BLEEDING); CENTRAL DIABETES INSIPIDUS; FLUIDS AND VOLUME EXPANDERS-RESUSCITATION
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;30MG/100ML;860MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 22 Mar 1971 |
| RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;30MG/100ML;860MG/100ML | solution · irrigation | OTSUKA ICU MEDCL | Prescription | 14 May 1976 |
| RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;30MG/100ML;860MG/100ML | solution · irrigation | B BRAUN | Prescription | 6 Aug 1979 |
| RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;30MG/100ML;860MG/100ML | injectable · injection | OTSUKA ICU MEDCL | Prescription | 16 May 1980 |
| RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;30MG/100ML;860MG/100ML | solution · irrigation | BAXTER HLTHCARE | Prescription | 19 Feb 1982 |
| RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;30MG/100ML;860MG/100ML | injectable · injection | B BRAUN | Prescription | 17 Apr 1992 |
| RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;30MG/100ML;860MG/100ML | injectable · injection | B BRAUN | Discontinued | 9 Nov 1982 |
| RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;30MG/100ML;860MG/100ML | solution · irrigation | ABBOTT | Discontinued |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.